18.05
price down icon0.22%   -0.04
after-market After Hours: 18.07 0.02 +0.11%
loading
Arcturus Therapeutics Holdings Inc stock is traded at $18.05, with a volume of 581.91K. It is down -0.22% in the last 24 hours and down -7.34% over the past month. Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
See More
Previous Close:
$18.09
Open:
$18.03
24h Volume:
581.91K
Relative Volume:
1.07
Market Cap:
$490.14M
Revenue:
$157.75M
Net Income/Loss:
$-29.73M
P/E Ratio:
-15.56
EPS:
-1.16
Net Cash Flow:
$-21.00M
1W Performance:
+0.33%
1M Performance:
-7.34%
6M Performance:
+27.47%
1Y Performance:
-14.09%
1-Day Range:
Value
$17.70
$18.59
1-Week Range:
Value
$16.54
$19.50
52-Week Range:
Value
$8.04
$25.88

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
Name
Arcturus Therapeutics Holdings Inc
Name
Phone
(858) 900-2660
Name
Address
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
Employee
176
Name
Twitter
@ArcturusRx
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ARCT's Discussions on Twitter

Compare ARCT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
18.05 491.23M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.15 100.34B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.50 60.95B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.73 60.46B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
734.35 46.04B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.20 36.02B 3.81B -644.79M -669.77M -6.24

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-04-25 Resumed H.C. Wainwright Buy
May-28-25 Initiated Scotiabank Sector Outperform
Jan-28-25 Initiated BTIG Research Buy
Aug-12-24 Initiated Leerink Partners Outperform
Dec-13-23 Initiated Canaccord Genuity Buy
Jul-24-23 Initiated William Blair Outperform
May-11-23 Upgrade H.C. Wainwright Neutral → Buy
Nov-14-22 Resumed Wells Fargo Overweight
Nov-10-22 Downgrade Robert W. Baird Neutral → Underperform
Nov-03-22 Upgrade Citigroup Neutral → Buy
Nov-02-22 Upgrade Barclays Underweight → Equal Weight
Aug-10-22 Downgrade Raymond James Mkt Perform → Underperform
Jul-19-22 Resumed Cantor Fitzgerald Overweight
May-11-22 Upgrade Robert W. Baird Underperform → Neutral
Apr-21-22 Downgrade Citigroup Buy → Neutral
Jan-31-22 Upgrade Raymond James Underperform → Mkt Perform
Aug-12-21 Downgrade Raymond James Mkt Perform → Underperform
Aug-11-21 Downgrade Goldman Neutral → Sell
Aug-10-21 Downgrade Robert W. Baird Neutral → Underperform
Jul-02-21 Initiated Cantor Fitzgerald Overweight
Jun-25-21 Resumed Goldman Neutral
Jun-21-21 Downgrade Barclays Equal Weight → Underweight
Jun-04-21 Resumed Robert W. Baird Neutral
Feb-17-21 Downgrade B. Riley Securities Neutral → Sell
Jan-19-21 Downgrade B. Riley Securities Buy → Neutral
Jan-15-21 Downgrade B. Riley Securities Buy → Neutral
Jan-07-21 Initiated Wells Fargo Overweight
Dec-29-20 Downgrade Barclays Overweight → Equal Weight
Dec-29-20 Downgrade H.C. Wainwright Buy → Neutral
Dec-29-20 Downgrade Raymond James Outperform → Mkt Perform
Dec-29-20 Downgrade Robert W. Baird Outperform → Neutral
Dec-23-20 Downgrade ROTH Capital Buy → Sell
Dec-08-20 Reiterated B. Riley Securities Buy
Dec-07-20 Reiterated B. Riley Securities Buy
Oct-26-20 Initiated Barclays Overweight
Oct-06-20 Initiated Citigroup Buy
Aug-26-20 Initiated Piper Sandler Overweight
Jul-30-20 Resumed ROTH Capital Buy
Jul-16-20 Initiated Raymond James Outperform
Jul-13-20 Initiated B. Riley FBR Buy
Jun-09-20 Downgrade WBB Securities Buy → Hold
Feb-11-20 Initiated Robert W. Baird Outperform
Feb-07-20 Initiated Guggenheim Buy
Feb-06-20 Initiated Guggenheim Buy
Apr-05-19 Initiated H.C. Wainwright Buy
Sep-20-18 Upgrade WBB Securities Buy → Strong Buy
Jan-22-18 Initiated Chardan Capital Markets Buy
View All

Arcturus Therapeutics Holdings Inc Stock (ARCT) Latest News

pulisher
Sep 17, 2025

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN

Sep 17, 2025
pulisher
Sep 17, 2025

Dynamic Technology Lab Private Ltd Invests $299,000 in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 5.4%Here's Why - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Highs Report: Is Arcturus Therapeutics Holdings Inc backed by strong institutional buying2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Goldman Sachs Group Inc. Acquires 42,636 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Risk Analysis: What’s the beta of Arcturus Therapeutics Holdings Inc. stockGDP Growth & AI Based Buy/Sell Signal Reports - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Arcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Woodline Partners LP - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Shorts Report: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesEarnings Beat & Capital Protection Trading Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Analyst Calls: Can Arcturus Therapeutics Holdings Inc sustain its profitability2025 Market Sentiment & Technical Pattern Based Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Decliners Report: Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersPortfolio Update Summary & Stock Timing and Entry Methods - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Inflation Data: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityWeekly Trend Summary & AI Enhanced Trading Signals - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

US Stocks Recap: Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Market Mood & Growth Focused Entry Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth - The Globe and Mail

Sep 15, 2025
pulisher
Sep 15, 2025

Will Arcturus Therapeutics Holdings Inc. benefit from macro trendsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Applying Elliott Wave Theory to Arcturus Therapeutics Holdings Inc.July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Applying big data sentiment scoring on Arcturus Therapeutics Holdings Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Visualizing Arcturus Therapeutics Holdings Inc. stock with heatmaps2025 Year in Review & Stepwise Trade Signal Guides - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Arcturus Therapeutics Holdings Inc. stock prediction for this weekIndex Update & Free Community Supported Trade Ideas - newser.com

Sep 14, 2025
pulisher
Sep 13, 2025

Will Arcturus Therapeutics Holdings Inc. stock recover after recent dropJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Jacobs Levy Equity Management Inc. Has $1.53 Million Stake in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

What is HC Wainwright's Estimate for ARCT Q3 Earnings? - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Invesco Ltd. Acquires 15,836 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 11, 2025
pulisher
Sep 09, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Coverage Initiated by Analysts at HC Wainwright - MarketBeat

Sep 09, 2025
pulisher
Sep 07, 2025

Will Arcturus Therapeutics Holdings Inc. benefit from rate cuts2025 Price Momentum & Capital Efficient Trade Techniques - beatles.ru

Sep 07, 2025
pulisher
Sep 07, 2025

Vestal Point Capital LP Acquires New Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Real time alert setup for Arcturus Therapeutics Holdings Inc. performanceWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Arcturus Therapeutics Holdings Inc. backed by strong institutional buyingJuly 2025 PreEarnings & Weekly Top Stock Performers List - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

American Century Companies Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - Defense World

Sep 06, 2025
pulisher
Sep 06, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Buy" by Analysts - MarketBeat

Sep 06, 2025
pulisher
Sep 06, 2025

Applying sector rotation models to Arcturus Therapeutics Holdings Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Automated trading signals detected on Arcturus Therapeutics Holdings Inc. - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Does Arcturus Therapeutics Holdings Inc. qualify in momentum factor screeningEarnings Recap Summary & Smart Money Movement Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Arcturus Therapeutics Holdings Inc. recovery potential after sell offMarket Activity Recap & Precise Entry and Exit Recommendations - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundEarnings Overview Report & Reliable Intraday Trade Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Live market analysis of Arcturus Therapeutics Holdings Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.Dip Buying & Long-Term Growth Stock Strategies - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Tools to monitor Arcturus Therapeutics Holdings Inc. recovery probabilityMarket Trend Review & High Conviction Buy Zone Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Support & Resistance & Weekly Momentum Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can you recover from losses in Arcturus Therapeutics Holdings Inc.Gap Down & Daily Risk Controlled Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Arcturus Therapeutics Holdings Inc. forming a reversal patternQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Vanguard Group Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Sep 04, 2025
pulisher
Sep 03, 2025

Is a relief rally coming for Arcturus Therapeutics Holdings Inc. holdersDividend Hike & Weekly Momentum Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Volume spikes in Arcturus Therapeutics Holdings Inc. stock – what they meanNew Guidance & Verified Trade Idea Suggestions - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visual trend scoring systems applied to Arcturus Therapeutics Holdings Inc.2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How institutional ownership impacts Arcturus Therapeutics Holdings Inc. stockRecession Risk & Low Risk Entry Point Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersEarnings Risk Summary & Stepwise Trade Signal Guides - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Top chart patterns to watch in Arcturus Therapeutics Holdings Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit Arcturus Therapeutics Holdings Inc.Forecast Cut & AI Based Buy and Sell Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Signal strength of Arcturus Therapeutics Holdings Inc. stock in tech scannersJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser

Sep 03, 2025

Arcturus Therapeutics Holdings Inc Stock (ARCT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.64
price up icon 0.62%
$84.80
price up icon 1.07%
$28.08
price down icon 0.57%
$98.15
price down icon 1.12%
$144.78
price up icon 0.02%
biotechnology ONC
$332.20
price up icon 1.53%
Cap:     |  Volume (24h):